PASSIGE: A new gene editing technique combines prime editing and evolved recombinases for precise, efficient integration of large genes, advancing gene therapy potential.
In a groundbreaking move, the United States Food and Drug Administration has recently given its nod to two pioneering cell-based gene therapies, Casgevy and